Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

New hair products are being developed to keep hair and scalp healthy for everyone.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

Improved Finasteride delivery for hair loss treatment.

New sensor detects minoxidil accurately and effectively.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Behavioral dermatology treats skin problems by considering both emotional and physical factors.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Researchers developed a model that shows hair follicles increase skin absorption of caffeine by 20%.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Custom-designed implants effectively repaired skull damage in most soldiers injured in combat.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.